Table 2.
Gram-positive organisms, % susceptibility | n | PCN | AMP | OX | VAN | TCN | SXT | CAM | CIP | CTX | |
---|---|---|---|---|---|---|---|---|---|---|---|
S. aureus | 17 | 0 | 0 | 53 | 100 | 71 | 65 | 76 | 65 | 53 | – |
S. pneumoniae | 3 | 67 | 67 | 100 | 100 | 67 | 67 | 100 | 0 | 100 | – |
Enterococcus spp. | 2 | 50 | 100 | 0 | 100 | 0 | N/A | 50 | 0 | 0 | – |
S. agalactiae | 1 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 0 | 100 | – |
S. pyogenes | 1 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 0 | 100 | |
Overall susceptibility | 24 | 17 | 25 | 58 | 100 | 67 | 67 | 79 | 46 | 58 | – |
Gram-negative organisms, % susceptibility | n | AMP | TCN | CAM | SXT | CIP | GEN | CTX | IPM |
---|---|---|---|---|---|---|---|---|---|
S. typhimurium | 9 | 0 | 67 | 0 | 0 | 89 | N/A | 55 | 100 |
S. enteritidis | 1 | 100 | 100 | 100 | 100 | 100 | N/A | 100 | 100 |
E. coli | 14 | 21 | 7 | 43 | 57 | 86 | 100 | 93 | 100 |
K. pneumoniae | 4 | 0 | 75 | 50 | 75 | 100 | 75 | 100 | |
Enterobacter spp. | 2 | 0 | 0 | 0 | 0 | 50 | 100 | 0 | 100 |
Citrobacter freundii | 1 | 0 | 0 | 0 | 0 | 100 | 100 | 100 | 100 |
Proteus vulgaris | 1 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Morganella morganii | 1 | 0 | 0 | 100 | 0 | 100 | 100 | 100 | 100 |
Acinetobacter baumanii | 1 | 0 | 0 | 0 | 0 | 0 | 100 | 0 | 100 |
Pseudomonas aeruginosa | 1 | 0 | 0 | 0 | 0 | 100 | 100 | 0 | 100 |
Overall susceptibility | 35 | 14 | 0 | 26 | 31 | 83 | 71 | 71 | 100 |
PCN = penicillin; AMP = ampicillin; OX: oxacillin; VAN = vancomycin; TCN = tetracycline; SXT = co-trimoxazole; CAM = chloramphenicol; CIP = ciprofloxacin; CTX: ceftriaxone; GEN = gentamicin; IPM = imipenem; N/A = not applicable.